These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11248405)

  • 1. Design, synthesis and binding properties of novel and selective 5-HT(3) and 5-HT(4) receptor ligands.
    Modica M; Santagati M; Guccione S; Russo F; Cagnotto A; Goegan M; Mennini T
    Eur J Med Chem; 2000 Dec; 35(12):1065-79. PubMed ID: 11248405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and binding properties of novel and selective 5-HT3 and 5-HT4 receptor ligands.
    Modica M; Santagati M; Guccione S; Russo F; Cagnotto A; Goegan M; Mennini T
    Eur J Med Chem; 2001 Mar; 36(3):287-301. PubMed ID: 11337106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and binding properties of novel selective 5-HT3 receptor ligands.
    Modica M; Romeo G; Materia L; Russo F; Cagnotto A; Mennini T; Gáspár R; Falkay G; Fülöp F
    Bioorg Med Chem; 2004 Jul; 12(14):3891-901. PubMed ID: 15210156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and receptor binding of new thieno[2,3-d]-pyrimidines as selective ligands of 5-HT(3) receptors.
    Modica MN; Romeo G; Salerno L; Pittalà V; Siracusa MA; Mereghetti I; Cagnotto A; Mennini T; Gáspár R; Gál A; Falkay G; Palkó M; Maksay G; Fülöp F
    Arch Pharm (Weinheim); 2008 Jun; 341(6):333-43. PubMed ID: 18535994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel potent 5-HT(3) receptor ligands based on the pyrrolidone structure: synthesis, biological evaluation, and computational rationalization of the ligand-receptor interaction modalities.
    Cappelli A; Anzini M; Vomero S; Mennuni L; Makovec F; Doucet E; Hamon M; Menziani MC; De Benedetti PG; Giorgi G; Ghelardini C; Collina S
    Bioorg Med Chem; 2002 Mar; 10(3):779-801. PubMed ID: 11814868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High affinity and selectivity of [[(arylpiperazinyl)alkyl]thio]thieno[2,3-d]pyrimidinone derivatives for the 5-HT(1A) receptor. Synthesis and structure-affinity relationships.
    Modica M; Santagati M; Russo F; Selvaggini C; Cagnotto A; Mennini T
    Eur J Med Chem; 2000; 35(7-8):677-89. PubMed ID: 10960183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pyridobenzodiazepine derivatives: modifications of the basic side chain differentially modulate binding to dopamine (D(4.2), D(2L)) and serotonin (5-HT(2A)) receptors.
    Liégeois JF; Eyrolles L; Ellenbroek BA; Lejeune C; Carato P; Bruhwyler J; Géczy J; Damas J; Delarge J
    J Med Chem; 2002 Nov; 45(23):5136-49. PubMed ID: 12408724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics.
    Raviña E; Negreira J; Cid J; Masaguer CF; Rosa E; Rivas ME; Fontenla JA; Loza MI; Tristán H; Cadavid MI; Sanz F; Lozoya E; Carotti A; Carrieri A
    J Med Chem; 1999 Jul; 42(15):2774-97. PubMed ID: 10425088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolizidinyl derivatives of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid and 1-homolupinanoyl benzimidazolones as ligands for 5-HT3 and 5-HT4 receptors.
    Sparatore A; Cagnotto A; Sparatore F
    Farmaco; 1999 Apr; 54(4):248-54. PubMed ID: 10384719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and preliminary pharmacological results on new naphthalene derivatives as 5-HT(4) receptor ligands.
    Diouf O; Depreux P; Chavatte P; Poupaert JH
    Eur J Med Chem; 2000; 35(7-8):699-706. PubMed ID: 10960185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptors.
    Yang D; Soulier JL; Sicsic S; Mathé-Allainmat M; Brémont B; Croci T; Cardamone R; Aureggi G; Langlois M
    J Med Chem; 1997 Feb; 40(4):608-21. PubMed ID: 9046352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a series of benzoxazoles as potent 5-HT6 ligands.
    Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1115-7. PubMed ID: 19152787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative receptor mapping of serotoninergic 5-HT3 and 5-HT4 binding sites.
    López-Rodríguez ML; Morcillo MJ; Benhamú B; Rosado ML
    J Comput Aided Mol Des; 1997 Nov; 11(6):589-99. PubMed ID: 9491351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzimidazole derivatives. Part 1: Synthesis and structure-activity relationships of new benzimidazole-4-carboxamides and carboxylates as potent and selective 5-HT4 receptor antagonists.
    López-Rodríguez ML; Benhamú B; Viso A; Morcillo MJ; Murcia M; Orensanz L; Alfaro MJ; Martín MI
    Bioorg Med Chem; 1999 Nov; 7(11):2271-81. PubMed ID: 10632037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Arylsulfonylindole derivatives as serotonin 5-HT(6) receptor ligands.
    Russell MG; Baker RJ; Barden L; Beer MS; Bristow L; Broughton HB; Knowles M; McAllister G; Patel S; Castro JL
    J Med Chem; 2001 Nov; 44(23):3881-95. PubMed ID: 11689074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzimidazole derivatives. 2. Synthesis and structure-activity relationships of new azabicyclic benzimidazole-4-carboxylic acid derivatives with affinity for serotoninergic 5-HT(3) receptors.
    López-Rodríguez ML; Benhamú B; Morcillo MJ; Tejada ID; Orensanz L; Alfaro MJ; Martín MI
    J Med Chem; 1999 Dec; 42(24):5020-8. PubMed ID: 10585211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands.
    Caliendo G; Fiorino F; Perissutti E; Severino B; Gessi S; Cattabriga E; Borea PA; Santagada V
    Eur J Med Chem; 2001; 36(11-12):873-86. PubMed ID: 11755230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and 5-HT3 receptor affinity of new quinolinecarboxylic acid derivatives.
    Orjales A; Alonso-Cires L; López-Tudanca PL; Tapia I; Labeaga L; Mosquera R
    Drug Des Discov; 2000; 16(4):271-9. PubMed ID: 10807033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
    J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.